Sudarshan Pharma Industries Financial Results

Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY

Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.

Key figure

Net profit ₹8.1 Cr · +92.9% YoY

Sudarshan Pharma Industries Board Meeting Date

Sudarshan Pharma's board meets 29 October 2026 to consider Q2 results and a fund-raising proposal. Trading window remains closed until 48 hours after results.

Sudarshan Pharma Industries SME to Main Board Migration

Sudarshan Pharma's shares will list on NSE's main board from October 27, 2026, migrating from BSE SME. Trading begins under symbol SUDARSHAN, marking a platform upgrade.

Sudarshan Pharma Industries Other Announcement

Sudarshan Pharma Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

Sudarshan Pharma Industries Merger & Restructuring

Sudarshan Pharma terminated its proposal to acquire 9.50% of Med Therapy Biotechnology Inc. The promoters' parallel 1.50% each acquisition plan also stands terminated.

Sudarshan Pharma Industries Merger & Restructuring Worth ₹1.4 Cr

Sudarshan Pharma Industries completed the sale of its 51% stake in subsidiary Ishwari Healthcare Private Limited for ₹1.40 Crore. The entity ceases to be a subsidiary.

Value

₹1.40 Cr

Rishi Techtex Q2 FY27 Results: Net Profit ₹0.4 Cr, Down 55.6% YoY

Rishi Techtex board approved Q2 and H1 FY27 unaudited results under Reg 33. Net profit was Rs.44.85 Lac for the quarter on Rs.4673.69 Lac income.

Key figure

Net profit ₹0.4 Cr · -55.6% YoY

TTK Healthcare Q2 FY27 Results: Net Profit ₹223 Cr, Up 993.1% YoY

TTK Healthcare Ltd reported revenue from operations of ₹233.4 Cr (+14.6% YoY) and net profit of ₹223 Cr (+993.1% YoY) for Q2 FY27.

Key figure

Net profit ₹223 Cr · +993.1% YoY

Intellect Design Arena Q2 FY27 Results: Net Profit ₹103.8 Cr, Up 1.9% YoY

Intellect Design Arena Ltd reported revenue from operations of ₹846.7 Cr (+11.7% YoY) and net profit of ₹103.8 Cr (+1.9% YoY) for Q2 FY27.

Key figure

Net profit ₹103.8 Cr · +1.9% YoY

Madhusudan Industries Q2 FY27 Results: Turns Profitable, Net Profit ₹0.3 Cr

Madhusudan Industries Ltd reported revenue from operations of ₹0.4 Cr (+33.3% YoY) and net profit of ₹0.3 Cr for Q2 FY27.

Key figure

Net profit ₹0.3 Cr

HLV Q2 FY27 Results: Net Loss of ₹7 Cr, Loss Narrows

HLV Ltd reported revenue from operations of ₹45.8 Cr (+27.9% YoY) and a net loss of ₹7 Cr for Q2 FY27.

Key figure

Net loss ₹7 Cr

Vimta Labs Q2 FY27 Results: Net Profit ₹20.6 Cr, Up 3.5% YoY

Vimta Labs Ltd reported revenue from operations of ₹112 Cr (+10.0% YoY) and net profit of ₹20.6 Cr (+3.5% YoY) for Q2 FY27.

Key figure

Net profit ₹20.6 Cr · +3.5% YoY